Mohamed L. Sorror

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0001-5260-1981

Also affiliated with University of Washington, Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades”.

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

Haematologica(2020)10.3324/haematol.2020.248187

N/A

1.3DataRank · unranked

39 citations

Barry E. Storer, Noa Granot, Boglark Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey +30 more

The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer

Journal of Palliative Medicine(2020)10.1089/jpm.2019.0530

N/A

0DataRank · unranked

34 citations

Ruth A. Engelberg, James Sibley, Mohamed L. Sorror, J. Randall Curtis, Cara L. McDermott

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

Haematologica(2020)10.3324/haematol.2020.254938

N/A

0DataRank · unranked

5 citations

Megan Othus, Sarah Mirahsani, Kelda M. Gardner, Carole Shaw, Anna B. Halpern +6 more

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.030

N/A

0DataRank · unranked

25 citations

Ajoy Dias, Tao Wang, Caitrin Fretham, Saurabh Chhabra, Hemant S. Murthy +30 more

CD19 CAR T-cell product type independently impacts CRS and ICANS severity in patients with aggressive NHL.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7532

N/A

0DataRank · unranked

5 citations

Aisling Cearley, Paula Perkins, Angela Kirk, Mazyar Shadman, Staci Williamson +10 more

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Blood(2022)10.1182/blood.2021014497

N/A

0DataRank · unranked

54 citations

Nicolas Gazeau, Alexandre V. Hirayama, Joshua A. Hill, Vicky Wu, Aisling Cearley +17 more

Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.015

N/A

0DataRank · unranked

27 citations

Kwang Woo Ahn, Manoj Khanal, Caitrin Bupp, Mariam Allbee‐Johnson, Navneet S. Majhail +24 more

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

Blood Advances(2022)10.1182/bloodadvances.2021006220

N/A

0DataRank · unranked

5 citations

Ted Gooley, Paul A. Carpenter, Mohamed L. Sorror, Margaret L. MacMillan, Todd E. DeFor +2 more

Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients

Blood Advances(2023)10.1182/bloodadvances.2023011002

N/A

0DataRank · unranked

30 citations

Ruta Brazauskas, Joelle Strom, Stella Chen, Stephanie Bo‐Subait, Akshay Sharma +24 more

Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients

medRxiv(2023)10.1101/2023.07.31.23293444

N/A

0DataRank · unranked

3 citations

Ruta Brazauskas, Joelle Strom, Stella Chen, Stephanie Bo‐Subait, Akshay Sharma +24 more

What makes a pediatric or young adult patient an appropriate transplant candidate?

Hematology(2023)10.1182/hematology.2023000519

N/A

0DataRank · unranked

0 citations

Mohamed L. Sorror, Monica S. Thakar

Development and validation of predictive models of early immune effector cell–associated hematotoxicity

Blood Advances(2024)10.1182/bloodadvances.2024014455

N/A

0DataRank · unranked

10 citations

Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz‐Maldonado, Aya Albittar, Natalie Wuliji +28 more

Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.07.022

N/A

0DataRank · unranked

3 citations

Michael A. Smith, Rachel Phelan, Ruta Brazauskas, Joelle Strom, Kwang Woo Ahn +11 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

Annals of Internal Medicine(2020)10.7326/m19-2936

N/A

0DataRank · unranked

278 citations

Brenda M. Sandmaier, Marco Mielcarek, Mohamed L. Sorror, Steven A. Pergam, Guang‐Shing Cheng +11 more

National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.031

N/A

0DataRank · unranked

0 citations

Helene Starks, Lindsey Bandini, T. Harrington, Mary‐Elizabeth M. Percival, Roland B. Walter +6 more